• WSJ

    • <h4>WSJ on Facebook</h4><div style="border: none; padding: 2px 3px;" class="fb-like" data-href="http://www.facebook.com/wsj" data-send="false" data-layout="button_count" data-width="250" data-show-faces="false" data-action="recommend"></div>
    • <h4>WSJ on Twitter</h4><a href="https://twitter.com/wsj" class="twitter-follow-button" data-show-count="true">Follow @wsj</a>
  • WSJ LIVE

    • WSJ Live on Facebook

    • WSJ Live on Twitter

  • MARKETWATCH

    • MarketWatch on Facebook

    • MarketWatch on Twitter

  • BARRON'S

    • Barron's on Facebook

    • Barron's on Twitter

  • Portfolio

    • Portfolio on Facebook

    • Portfolio on Twitter

  • DJX

    • Product X on Facebook

    • Product X on Twitter

    • RT
    • F
    • R&C
    • PE&VC
    • WSJ
    • B
  • MORE

    • WSJ Secure
    • BigCharts
    • DJX
    • Portfolio
    • WSJ Live
    • Financial News
    • Professor Journal
    • Student Journal
    • Virtual Stock Exchange
    • WSJ Classifieds
    • WSJ Classrooms
    • WSJ Radio
    • WSJ Wine
The Wall Street Journal
Menu
  • Home
  • World
  • U.S.
  • Business
  • Tech
  • Markets
  • Market Data
  • Your Money
  • Opinion
  • Life & Culture
  • N.Y.
  • Real Estate
  • Management

Also in WSJ.com:

  • Latest News
  • Today's Paper
  • Most Popular
  • Streams (TBD)
  • Video
  • Blogs

International Editions

  • U.S.
  • Asia
  • Europe
  • América Latina
  • Brasil
  • 中文-简体(China)
  • Deutschland
  • India
  • Indonesia
  • 日本(Japan)
  • 한국(Korea)
  • Türkiye
Market Data
  • Log In
  • Subscribe

Edwards Lifesciences Corp. EW (U.S.: NYSE)

View All companies
  • AT CLOSE 4:00 PM ET 09/04/14
  • $98.44 USD
  • 0.53 0.54%
  • Volume 772,419
  • AFTER HOURS 4:25 PM ET 09/04/14
  • $98.44 0.00 0
  • AFTER HOURS Vol 1,907
  • Volume 772,419
  • 65 Day Avg Vol 1,027,087
  • 1 Day Range 97.59 - 98.86
  • 52 Week Range 60.62 - 99.52 (12/13/13 - 09/02/14)
  • 1 Day
  • 5 Day
  • 1 Month
  • 3 Month
  • YTD
  • 1 Year
  • 3 Year
  • $
  • %
Compare
  • Compare to Benchmark:
  • DJIA
  • S&P 500
  • GLOBAL DOW
  • NASDAQ
  • Health Care
  • Compare to
  • Today's Open 98.06
  • Prior Day Close 97.91 (09/03/14)
  • Performance Today
  • EW 0.54%
  • DJIA -0.05%
  • S&P 500 -0.15%
  • Health Care -0.60%
Company Overview

Latest News Edwards Lifesciences Corp.(EW)

    • 09/03/14
    • Press Release
    Novation Enters Into First Sole-Source Heart Valve Agreement With Edwards Lifesciences
    • Press Release
    • 08/04/14
    • Press Release
    Use of Priority Review Voucher and Financial Result Releases of Healthcare Companies - Research Reports on Regeneron, WellPoint, Edwards, Humana and Celgene
    • Press Release
    • 08/02/14
    • Barron's
    Charting the Market
    • Barron's
    • 07/30/14
    • Dow Jones Newswires
    U.S. Hot Stocks: Hot Stocks to Watch
    • Dow Jones Newswires
    • 07/29/14
    • The Wall Street Journal
    Edwards Lifesciences Profit Soars
    • The Wall Street Journal
    • 07/29/14
    • Press Release
    Edwards Lifesciences Reports Strong Second Quarter Results
    • Press Release
    • 07/29/14
    • Press Release
    Health Care Sector Equities Coverage -- AmerisourceBergen, Cardinal Health, McKesson, CareFusion, and Edwards Lifesciences
    • Press Release
    • 07/22/14
    • Press Release
    Edwards' CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation
    • Press Release
    • 07/15/14
    • Press Release
    Edwards Lifesciences To Host Earnings Conference Call on July 29, 2014
    • Press Release
    • 07/04/14
    • Press Release
    Upcoming Earnings, Donations, FDA Approvals, Mortality Reduction Commitments, and New Monitoring Platform - Analyst Notes on Boston Scientific, ResMed, Edwards, Masimo and NuVasive
    • Press Release
    • 06/30/14
    • Press Release
    Edwards Receives FDA Clearance For Advanced Noninvasive Monitoring System
    • Press Release
    • 06/19/14
    • Press Release
    Product Launch, Manufacturing Site Licensure, Technology Exhibition, and Technical Updates - Analyst Notes on Edwards Lifesciences, Hologic, Novartis, CareFusion and DaVita
    • Press Release
    • 06/17/14
    • WSJ Blogs
    Stocks to Watch: Edwards Lifesciences, Amira, Forest Oil
    • WSJ Blogs
    • 06/17/14
    • Dow Jones Newswires
    U.S. Hot Stocks: Hot Stocks to Watch
    • Dow Jones Newswires
    • 06/17/14
    • MarketWatch.com
    Edwards Lifesciences gets FDA OK for new heart valve
    • MarketWatch.com
    • 06/16/14
    • The Wall Street Journal
    New Heart-Valve Procedure Sparks Doctors' Concern
    • The Wall Street Journal
    • 06/16/14
    • Dow Jones Newswires
    Edwards Lifesciences Gets FDA Approval for Sapien XT Heart Valve
    • Dow Jones Newswires
    • 06/16/14
    • Press Release
    Edwards Lifesciences Launching SAPIEN XT Valve In The U.S.
    • Press Release
    • 06/11/14
    • Dow Jones Newswires
    Edwards Lifesciences Raised to Mkt Outperform From Mkt Perform by JMP Securities
    • Dow Jones Newswires
    • 06/06/14
    • Press Release
    Momentum Indicators for Health Care Equipment and Supplies Stocks -- Research on Edwards Lifesciences, Hansen Medical, Spectranetics, and Align Technology
    • Press Release
    • 06/03/14
    • Press Release
    Cash Dividends, Conference Presentations, Pricing of Offering, and Senate's Statement - Analyst Notes on Universal Health Services, AmSurg, Spectranetics, Edwards Lifesciences and Spherix
    • Press Release
    • 05/29/14
    • Press Release
    Edwards Lifesciences to Present at Upcoming Investor Conferences
    • Press Release
    • 05/23/14
    • Press Release
    Relief Efforts, Rights Acquisitions, Recognition, and Settlements - Analyst Notes on UnitedHealth Group, Endo, Baxter, Edwards Lifesciences and Aetna
    • Press Release
    • 05/20/14
    • The Wall Street Journal
    Medtronic Settles Edwards Lifesciences Patent Suit, Profit Drops
    • The Wall Street Journal
    • 05/20/14
    • WSJ Blogs
    Stocks to Watch: Staples, TJX, Urban Outfitters
    • WSJ Blogs
    • 05/20/14
    • Dow Jones Newswires
    U.S. Hot Stocks: Hot Stocks to Watch
    • Dow Jones Newswires
    • 05/20/14
    • Dow Jones Newswires
    Medtronic Settles Edwards Lifesciences Patent Suit, Profit Drops--Update
    • Dow Jones Newswires
    • 05/20/14
    • Dow Jones Newswires
    Medtronic Settles Patent Dispute With Edwards, Earnings Drop
    • Dow Jones Newswires
    • 05/20/14
    • Press Release
    Early Patient Cases With Fortis Valve Presented at EuroPCR 2014
    • Press Release
    • 05/20/14
    • Press Release
    Excellent Early Experience Reported With Edwards SAPIEN 3 Transcatheter Valve
    • Press Release
    • 05/20/14
    • Press Release
    Edwards Lifesciences, Medtronic Agree to Global Transcatheter Valve Litigation Settlement
    • Press Release
    • 05/12/14
    • Press Release
    Health Care Sector Stocks Coverage -- Research on Accuray, Varian Medical Systems, Intuitive Surgical, and Edwards Lifesciences
    • Press Release
    • 05/08/14
    • WSJ Blogs
    Take Two: Recusals Spur Patent-Case Revisions
    • WSJ Blogs
    • 04/30/14
    • Press Release
    EDWARDS INTUITY Valve Data Demonstrate Improved Patient Benefits Over Standard Surgical Valves
    • Press Release
    • 04/28/14
    • Press Release
    Edwards Lifesciences Launches Philanthropic Initiative to Impact Global Burden of Heart Valve Disease
    • Press Release
    • 04/24/14
    • The Wall Street Journal
    Edwards Lifesciences Revenue Rises on Nonsurgical Heart Valves
    • The Wall Street Journal
    • 04/21/14
    • The Wall Street Journal
    Medtronic Can Sell Heart Valve After Appeals Court Delays Ban
    • The Wall Street Journal
    • 04/19/14
    • Barron's
    Charting the Market
    • Barron's
    • 04/19/14
    • Barron's
    Charting the Market
    • Barron's
    • 04/18/14
    • The Wall Street Journal
    'My Father Is Going to Die From Red Tape'
    • The Wall Street Journal
load more
Key Stock Data
?
P/E Ratio (TTM)
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period.
Earnings Per Share (TTM)
A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding.
Market Capitalization
Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple common share classes, market capitalization includes both classes.
Shares Outstanding
Number of shares that are currently held by investors, including restricted shares owned by the company's officers and insiders as well as those held by the public.
Public Float
The number of shares in the hands of public investors and available to trade. To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded.
Dividend Yield
A company's dividend expressed as a percentage of its current stock price.

Key Stock Data

  • P/E Ratio (TTM)
    13.81 (09/04/2014)
  • EPS (TTM)
    $7.13
  • Market Cap
    $10.38 B
  • Shares Outstanding
    105.49 M
  • Public Float
    104.31 M
  • Yield
    EW has not issued dividends in more than 1 year.
  • Latest Dividend
    N/A
  • Ex-Dividend Date
    N/A
?
Shares Sold Short
The total number of shares of a security that have been sold short and not yet repurchased.
Change from Last
Percentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month.
Percent of Float
Total short positions relative to the number of shares available to trade.

Short Interest

  • Shares Sold Short
    2.94 M (08/15/2014)
  • Change from Last
    +0.70%
  • Percent of Float
    2.81%
?
Money Flow Uptick/Downtick Ratio
Money flow measures the relative buying and selling pressure on a stock, based on the value of trades made on an "uptick" in price and the value of trades made on a "downtick" in price. The up/down ratio is calculated by dividing the value of uptick trades by the value of downtick trades. Net money flow is the value of uptick trades minus the value of downtick trades. Our calculations are based on comprehensive, delayed quotes.

Stock Money Flow

  • Uptick/Downtick Trade Ratio
    0 2
    1.08
    Net Money Flow ($)
    +1.07 M

    Money flow gives a snapshot of relative buying and selling pressure in a stock. A ratio above one suggests greater buying pressure, below one suggests greater selling.

Advertisement

Competitors (EW)

Company Change P/E (TTM)
WST

West Pharmaceutical Services Inc.

-0.59% -0.26 27.07
THOR

Thoratec Corp.

-0.36% -0.09 21.14
COLOB

Coloplast A/S Series B

+0.50% +2.40 44.01
BSX

Boston Scientific Corp.

-1.61% -0.20 68.27
BCR

C.R. Bard Inc.

-0.04% -0.06 15.06
COH

Cochlear Ltd.

-1.49% -1.06 42.60
STMN

Straumann Holding AG

-0.62% -1.40 30.22
DXCM

DexCom Inc.

-2.07% -0.90 -
STJ

St. Jude Medical Inc.

-0.26% -0.17 20.62
CFN

CareFusion Corp.

-0.24% -0.11 23.08
  • Competitor Data Provided By: capital cube

Profile (EW)

Edwards Lifesciences Corp. designs, develops, manufactures and markets products to treat stage cardiovascular disease. Its products and technologies are categorized into four areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves and Critical Care. The Surgical...

One Edwards Way
Irvine California 92614
United States

  • Email
  • Website
  • Map
  • Employees 8,600
    Sector Medical Supplies
  • Sales or Revenue 2.05 B
    Industry Health Care
  • 1Y Sales Change 7.68%
    Fiscal Year Ends December 31 Download Reports
  • Michael A. Mussallem Chairman & Chief Executive Officer
  • Scott B. Ullem Chief Financial Officer & Vice President
  • John P. McGrath Vice President-Quality, Regulatory & Clinical
  • Stanton J. Rowe Chief Scientific Officer & VP-Advanced Technology
  • More

Research & Ratings Edwards Lifesciences Corp.(EW)

Per-Share Earnings, Actuals and Estimates

EW will report FY 2014 earnings on 02/02/2015 EW will report Q3 earnings on 10/22/2014
  • Quarterly
  • Annual
Actual Analyst Range Consensus
1.50 1.00 0.50 0.00
Actual 0.68
0.66
Actual 0.91
0.82
Actual 0.76
0.68
Actual 0.88
0.77
0.72
0.94
Q32013 Q4 Q12014 Q2 Q3 Q4
6.00 4.00 2.00 0.00
Actual 3.44
3.05
3.29
3.80
4.32
FY 2013 FY 2014 FY 2015 FY 2016
Q3 2014 Estimate Trends
Current: $0.72
1 month ago: $0.72
3 months ago: $0.72
Q4 2014 Estimate Trends
Current: $0.94
1 month ago: $0.95
3 months ago: $0.89
FY 2014 Estimate Trends
Current: $3.29
1 month ago: $3.29
3 months ago: $3.14
FY 2015 Estimate Trends
Current: $3.80
1 month ago: $3.77
3 months ago: $3.59
  • More

Financials Edwards Lifesciences Corp.(EW)

  • Quarterly
  • Annual

Net Income

0 200M 400M 600M
Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014
0 100M 200M 300M 400M
'09 '10 '11 '12 '13
Jun 2014 5-quarter trend
Net Income Growth +481.30%
Sales or Revenue 575.10 M
Sales or Revenue Growth +11.19%
EBITDA +132.40 M
2013 5-year trend
Net Income Growth +33.59%
Sales or Revenue 2.05 B
Sales or Revenue Growth +7.68%
EBITDA +501.70 M
  • More

Notes & Data Providers

Real-time U.S. stock quotes reflect trades reported through Nasdaq only. U.S. stock quote data and real-time U.S. stock indexes provided by Dow Jones.

International stock quotes are delayed as per exchange requirements. Indexes may be real-time or delayed; refer to time stamps on index quote pages for information on delay times.

Quote data, except U.S. stocks, provided by SIX Financial Information.

Data is provided "as is" for informational purposes only and is not intended for trading purposes. SIX Financial Information (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Data may be intentionally delayed pursuant to supplier requirements.

Bond quotes are updated in real-time. Source: Tullett Prebon PLC, ICAP PLC.

Currency quotes are updated in real-time. Source: ICAP PLC.

Advertisement
  • Wall Street Journal
  • Facebook
  • Twitter
  • LinkedIn
  • FourSquare
  • Google+
  • YouTube
  • Podcasts
  • RSS Feed
  • AppStore
  • Subscribe
  • /Login
  • Back to Top«
  • Customer Service

  • Customer Center
  • Contact Us
  • WSJ Weekend
  • Contact Directory
  • Corrections
  • Policy

  • Privacy Policy
  • Cookie Policy
  • Data Policy
  • Copyright Policy
  • Updated :  Subscriber Agreement
    & Terms of Use
  • Your Ad Choices
  • Ads

  • Advertise
  • Place a Classified Ad
  • Sell Your Home
  • Sell Your Business
  • Commercial Real Estate Ads
  • Recruitment & Career Ads
  • Franchising
  • Advertise Locally
  • Tools & Features

  • Apps
  • Emails & Alerts
  • Graphics & Photos
  • Columns
  • Topics
  • Guides
  • Portfolio
  • Old Portfolio
  • More

  • Register for Free
  • Reprints
  • Content Partnerships
  • Conferences
  • Mobile Site
  • News Archive
  • Jobs at WSJ
  • Copyright ©2014 Dow Jones & Company, Inc. All Rights Reserved.